Embryonic Stem Cell Therapy (Rinri Therapeutics)

N/A

Report date: 2025/01/26 17:13:52

Base Information

Drug NameEmbryonic Stem Cell Therapy (Rinri Therapeutics)
Drug Alias NameAuditory Stem Cell Therapy (Rinri Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHearing Loss, SensorineuralHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Sheffield
China Registration ClassN/A

Develop Information

Active CompaniesRinri Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsHearing Loss, SensorineuralHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A